Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced or Metastatic Solid Tumor Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT05019794
What this trial is testing

Infigratinib in Subjects With GC or GEJ With FGFR2 Amplification or Other Solid Tumors With Other FGFR Alterations

Who this might be right for
Gastric CancerGastroesophageal Junction AdenocarcinomaSolid Tumor
LianBio LLC 80
Early research (Phase 1)Ended earlyNCT04167137
What this trial is testing

Safety and Tolerability of SYNB1891 Injection Alone or in Combination With Atezolizumab in Adult Participants

Who this might be right for
Metastatic Solid NeoplasmLymphoma
Synlogic 32
Early research (Phase 1)Ended earlyNCT05631327
What this trial is testing

A JZP341 Study in Adult Participants With Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced Solid TumorMetastatic Solid Tumor
Jazz Pharmaceuticals 12
Early research (Phase 1)Not Yet RecruitingNCT06755242
What this trial is testing

GNC-077 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumors and Other Solid Tumors

Who this might be right for
Gastrointestinal TumorsSolid Tumor
Sichuan Baili Pharmaceutical Co., Ltd. 20
Early research (Phase 1)Not Yet RecruitingNCT06724042
What this trial is testing

Study of ISM5939 in Patients With Advanced and/or Metastatic Solid Tumors

Who this might be right for
Advanced Solid TumorMetastatic Solid TumorAdvanced and/or Metastatic Solid Tumors
InSilico Medicine Hong Kong Limited 159
Early research (Phase 1)Study completedNCT01875705
What this trial is testing

A Dose-Escalation Study of GDC-0994 in Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Solid Tumor
Genentech, Inc. 40
Early research (Phase 1)UnknownNCT01107522
What this trial is testing

Safety and Tolerability of Carboxyamidotriazole Orotate (CTO) in Solid Tumors or With Temodar® in Glioblastoma or Other Recurrent Malignant Gliomas or in Combination With Temodar® and Radiation Therapy for Patients With Newly Diagnosed Glioblastoma and Malignant Gliomas

Who this might be right for
Solid Tumors, Glioblastoma, Recurrent Malignant Gliomas
Tactical Therapeutics, Inc. 100
Early research (Phase 1)Study completedNCT00848718
What this trial is testing

A Phase I Study of MK-2206 in Combination With Standard Chemotherapy in Participants With Locally Advanced or Metastatic Solid Tumors (MK-2206-003)

Who this might be right for
Locally Advanced, Metastatic Solid Tumors
Merck Sharp & Dohme LLC 77
Testing effectiveness (Phase 2)Looking for participantsNCT06016062
What this trial is testing

RC148 As a Single Agent and Combination Therapy in Patients with Locally Advanced Unresectable or Metastatic Malignant Solid Tumors

Who this might be right for
Solid Tumor
RemeGen Co., Ltd. 221
Early research (Phase 1)Study completedNCT01125891
What this trial is testing

Dose Escalation Study of Gemcitabine and ON 01910.Na in Solid Tumors

Who this might be right for
Malignant NeoplasmasSolid Tumors
Traws Pharma, Inc. 39
Early research (Phase 1)Looking for participantsNCT06826313
What this trial is testing

Intravenous VRT106 for Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Solid Tumors
Guangzhou Virotech Pharmaceutical Co., Ltd. 12
Early research (Phase 1)Study completedNCT01245205
What this trial is testing

Akt Inhibitor MK2206 in Combination With Lapatinib Ditosylate in Patients With Advanced or Metastatic Solid Tumors or Breast Cancer

Who this might be right for
HER2-positive Breast CancerMale Breast CancerRecurrent Breast Cancer+4 more
National Cancer Institute (NCI) 28
Testing effectiveness (Phase 2)Looking for participantsNCT06566079
What this trial is testing

Study of ISM6331 in Participants With Advanced/Metastatic Mesothelioma or Other Advanced Solid Tumors

Who this might be right for
Malignant MesotheliomaMetastatic Malignant Solid TumorAdvanced Solid Tumor
InSilico Medicine Hong Kong Limited 160
Early research (Phase 1)Ended earlyNCT06585488
What this trial is testing

A First-in-human Study of BGB-53038, a Pan-KRAS Inhibitor, Alone or in Combinations in Participants With Advanced or Metastatic Solid Tumors With KRAS Mutations or Amplification

Who this might be right for
Metastatic Solid TumorsAdvanced Non-squamous Non-small-cell Lung CancerAdvanced Colorectal Cancer+4 more
BeOne Medicines 47
Testing effectiveness (Phase 2)Study completedNCT00003103
What this trial is testing

Chemotherapy in Treating Patients With Solid Tumors

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+7 more
Memorial Sloan Kettering Cancer Center 57
Testing effectiveness (Phase 2)Looking for participantsNCT06827613
What this trial is testing

Invikafusp Alfa (STAR0602), a Selective T Cell Receptor (TCR)-Targeting, Bifunctional Antibody-fusion Molecule, in Combination With Sacituzumab Govitecan in Participants With Advanced Solid Tumors

Who this might be right for
Triple Negative Locally Advanced Non-resectable Breast CancerHR+, HER2-, Advanced Breast Cancer
Marengo Therapeutics, Inc. 50
Early research (Phase 1)UnknownNCT05263180
What this trial is testing

EMB-09 in Participants With Advanced or Metastatic Solid Tumors.

Who this might be right for
Advanced Solid Tumor
Shanghai EpimAb Biotherapeutics Co., Ltd. 30
Testing effectiveness (Phase 2)Looking for participantsNCT07602842
What this trial is testing

IDP-001 in Advanced or Metastatic Solid Tumors

Who this might be right for
Advanced Solid TumorMetastatic Solid TumorHead and Neck Squamous Cell Carcinoma+6 more
InduPro, Inc. 132
Early research (Phase 1)Study completedNCT02220049
What this trial is testing

Dose Escalation of Velcade Daily Dose in Patients With Solid Tumors

Who this might be right for
Advanced or Metastatic Solid Tumors
Gustave Roussy, Cancer Campus, Grand Paris 18
Early research (Phase 1)Study completedNCT01199822
What this trial is testing

Study of the Safety and Pharmacokinetics of Olaratumab (IMC-3G3) in Japanese Participants With Solid Tumors

Who this might be right for
MalignancyMetastasis
Eli Lilly and Company 16
Next Page